System1 Group PLC

PDMR Shareholding

RNS Number : 4126G
System1 Group PLC
06 November 2018



Press Release

05 November 2018



System1 Group PLC (AIM: SYS1)

formerly BrainJuicer Group PLC

("System1", or "the Company", or "the Group")


PDMR Shareholding


System1 announces that on 5 November 2018, Stefan Barden, PDMR, purchased 261,850 ordinary shares in the Company ("Shares") at 190 pence per share.  


As a result of this transaction, Stefan now holds 357,088 Shares, representing 2.8% of the Company's voting share capital.


The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.


Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014


Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA")


Stefan Barden

Reason for the notification

Position / status


Initial notification / amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor


System1 Group PLC

Legal Entity Identifier


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument

Ordinary Shares


Nature of the transaction

Purchase of Ordinary Shares

Price(s) and volume(s)



190 pence


Aggregated information

-     Aggregated volume

-     Aggregated price

-     Aggregated total


N/A - single transaction

Date of the transaction

5 November 2018 (UK)

Place of the transaction

London Stock Exchange, AIM



The Company can be found at



For further information, please contact:

System1 Group PLC

Tel: +44 (0)20 7043 1000


John Kearon, Chief Executive Officer


James Geddes, Chief Financial Officer


Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

Simon Bridges / Emma Gabriel


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit